Company intelligence / Profile preview

Burford Capital

New York, New York, USA

Ownership: Private
Employees: ~160
Development stage: Other

Overview

Burford Capital is a global leader in commercial litigation finance, frequently supporting companies (including those in healthcare, biotech, and pharma) on matters of patent enforcement, IP monetization, and complex litigation/arbitration. The company is public, substantial in scale, operates globally, but is not a drug/biotech/healthcare developer or platform company. Its impact on healthcare is indirect—via legal and IP finance—not via therapies or health innovations.

Industry: Investors

Partnerships

law firmsFortune 500 and FTSE 350 companies for legal finance

Beyond the preview

Go deeper on Burford Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Burford Capital.

Explore the full profile